| Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial C Male, AWA Lensing, JS Palumbo, R Kumar, I Nurmeev, K Hege, ... The Lancet Haematology 7 (1), e18-e27, 2020 | 227 | 2020 |
| Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT) P Connor, M Sánchez van Kammen, AWA Lensing, E Chalmers, K Kállay, ... Blood advances 4 (24), 6250-6258, 2020 | 66 | 2020 |
| Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE) K Thom, AWA Lensing, I Nurmeev, F Bajolle, D Bonnet, G Kenet, ... Blood advances 4 (19), 4632-4639, 2020 | 39 | 2020 |
| Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles KM Kidwell, S Roychoudhury, B Wendelberger, J Scott, T Moroz, S Yin, ... Orphanet Journal of Rare Diseases 17 (1), 186, 2022 | 17 | 2022 |
| EINSTEIN-Jr phase 3 investigators. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled … C Male, AWA Lensing, JS Palumbo, R Kumar, I Nurmeev, K Hege, ... Lancet Haematol 7 (1), e18-e27, 2020 | 9 | 2020 |
| Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr JS Palumbo, AWA Lensing, LR Brandão, HL Hooimeijer, G Kenet, ... Blood advances 6 (22), 5821-5828, 2022 | 4 | 2022 |
| Randomised controlled trial of rivaroxaban compared to standard anticoagulants for the treatment of acute venous thromboembolism in children C Male, AWA Lensing, JS Palumbo, R Kumar, I Nurmeev, K Hege, ... | 4 | 2019 |
| Elaborator: a novel app for insights into laboratory data of clinical trials S Janitza, M Majumder, F Mendolia, S Jeske, H Kulmann Therapeutic Innovation & Regulatory Science 55, 1220-1229, 2021 | 2 | 2021 |
| Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation B Ratitch, A Trigg, M Majumder, V Vlajnic, N Rethemeier, R Nkulikiyinka Digital Biomarkers 7 (1), 74-91, 2023 | | 2023 |
| Correction to: Response to the Letter to the Editor by Koneswarakantha and Ménard S Janitza, M Majumder, F Mendolia, S Jeske, H Kulmann Therapeutic Innovation & Regulatory Science 56 (3), 381-381, 2022 | | 2022 |
| Response to the Letter to the Editor by Koneswarakantha and Ménard S Janitza, M Majumder, F Mendolia, S Jeske, H Kulmann Therapeutic Innovation & Regulatory Science 56 (3), 379-380, 2022 | | 2022 |
| Correction to: elaborator: A Novel App for Insights into Laboratory Data of Clinical Trials S Janitza, M Majumder, F Mendolia, S Jeske, H Kulmann Therapeutic Innovation & Regulatory Science 55, 1230-1230, 2021 | | 2021 |
| elaborator: A 'shiny' Application for Exploring Laboratory Data H Janitza, S., Jeske, S., Majumder, M., Mendolia, F., Kulmann R Package, 2020 | | 2020 |
| Conditional Tests for Multivariate One-sided Hypotheses with Missing Data M Majumder University of Rochester, 2018 | | 2018 |
| Analysis of participant withdrawal in Huntington disease clinical trials H Banno, KL Andrzejewski, MP McDermott, A Murphy, M Majumder, ... Journal of Huntington's disease 6 (2), 149-156, 2017 | | 2017 |
